Wednesday, April 2, 2025
4/2/2025
Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease - Mitochondrial dysfunction and oxidative stress play key roles in Parkinson’s disease (PD). PGC-1α is a master regulator of mitochondrial biogenesis and antioxidant defenses. PGC-1α deficiency plays a key role in dopaminergic (DA) neuronal survival, including vulnerability to α-synuclein (αSyn) toxicity, and also potentially in Alzheimer’s disease. However, viral vector mediated overexpression of PGC-1α at high levels causes DA neurons to degenerate and increases susceptibility to MPTP toxicity. Thus, harnessing the therapeutic potential of PGC-1α likely requires normalization (or only mild elevation) of its expression levels in neurons. Achieving this requires a better understanding of mechanisms regulating PGC-1α. We hypothesize that chaperone-mediated autophagy (CMA) regulates PGC-1α indirectly by regulating FBW7, a multi-subunit E3 ubiquitin ligase that promotes the degradation of critical regulatory proteins, including PGC-1α. We have found that SCFFBW7 harbors the perfect CMA consensus sequence, “KFERQ”, and that increasing CMA decreases FBW7 and increases PGC-1α protein levels. We hypothesize that CMA degrades FBW7, thus reducing UPS-mediated degradation of PGC-1α: ↑CMA ↓ FBW7 ↑ PGC-1α . FBW7 is a target of PRKN, with Prkn loss leading to increased FBW7 in Prkn-null mice, which in turn reduces levels of the anti-apoptotic factor Mcl-1. Furthermore, brain FBW7 levels are increased in PD patients with PRKN mutations. Thus, FBW7 is a potential therapeutic target in PD, but our understanding of mechanisms regulating FBW7 is limited. To this end, we have preliminary data implicating that p300/SIRT1 dependent regulation of FBW7 acetylation plays a potentially key role in regulating FBW7 levels. p300/SIRT1 also interact directly with PGC-1α, and thus may represent a homeostatic mechanism for maintaining stable levels of PGC-1α activity. We now propose first to analyze molecular mechanisms that regulate FBW7 and PGC-1α, and then will specifically test our hypothesis that reducing SCFFBW7 in DA neurons will protect against αSyn toxicity in a mouse model of PD.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).